NDC11 00168020130
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00168-0201-30 | 00168-0201 |
| 00168-201-30 | 00168-201 |
| 0168-0201-30 | 0168-0201 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 62a2019f-7410-4251-95ed-181925ade6e4 | 2026-01-28 | Warnings, Adverse reactions | 0168-0201-30 0168-0201 00168020130 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.